Vinci Pharmaceuticals Inc. Closes More Than $8 Million Series A Financing to Advance EPIPLANT™ Drug Delivery Platform
Key Takeaways AVON-BY-THE-SEA, N.J., Oct. 8, 2026 /PRNewswire/ — Vinci Pharmaceuticals Inc., a specialty ophthalmic pharmaceutical company, has closed an $8+ million Series A financing round as the company advances development of
